Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Vera Therapeutics (VERA) Long-Term Debt Issuances (2020)

Vera Therapeutics posted quarterly Long-Term Debt Issuances of $602000.0 for Q2 2020, down 87.96% on a QoQ basis from $5.0 million in Q1 2020.

Vera Therapeutics (VERA) has 1 years of Long-Term Debt Issuances data on file, last reported at $602000.0 in Q2 2020.

  • For the quarter ending Q2 2020, Long-Term Debt Issuances changed N/A year-over-year to $602000.0; the trailing twelve-month figure through Dec 2020 stood at $5.6 million (changed N/A YoY), and the FY2020 full-year result was $5.6 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q2 2020 stood at $602000.0, down from $5.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $5.0 million in Q1 2020 and bottomed at $602000.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.73 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Vera Therapeutics 2.43 Bn 1.83 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 602,000.00
Jun 30, 2020 602,000.00
Mar 31, 2020 5.00 Mn
Mar 31, 2020 5.00 Mn